Hyperprolactinemia Associated with Drugs
At a Glance
Hyperprolactinemia is the most common endocrine disorder of the hypothalamic-pituitary unit. In premenopausal women, hyperprolactinemia causes hypogonadism, leading to symptoms of infertility, oligomenorrhea or amenorrhea, and galactorrhea. Hyperprolactinemia is often clinically silent in postmenopausal women who, by definition, are already hypogonadal. In men, hyperprolactinemia causes hypogonadism manifested by decreased libido, impotence, infertility, and, rarely, galactorrhea.
Several drugs are known to cause minimal to moderate hyperprolactinemia:
Selective serotonin reuptake inhibitors
H2-receptor blocking agents
Opiates and Opiate Antagonists
These should be ruled-out as potential causes of hyperprolactinemia prior to investigating organic causes.
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
Measurement of serum prolactin is necessary to identify hyperprolactinemia. Testing can be performed without regard to time of day, because routine daily activities have little influence on prolactin concentration.
Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?
Prolactin concentrations slightly greater than the reference interval should be confirmed by repeat testing on a new blood sample, because prolactin may be influenced by strenuous exercise, emotional or physical stress, or rigorous stimulation of breast tissue.
Macroprolactin is a complex of prolactin and IgG and is a source of hyperprolactinemia in some individuals. Because of its high molecular mass, macroprolactin has prolonged clearance that can cause an apparent hyperprolactinemia. In the absence of clinical symptoms, hyperprolactinemia due to macroprolactin can cause clinical confusion. It is important to be aware that macroprolactinemia can coexist with true hyperprolactinemia.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
The Cardiology Advisor Articles
- USPSTF Does Not Recommend Electrocardiography Screening in Low-Risk CVD
- CTEPH Increases Risk for Sleep Disordered Breathing
- Many AKI Reports in FAERS Linked to Drugs Not Recognized as Nephrotoxic
- Sildenafil, Bosentan Combination vs Sildenafil Monotherapy in SSc-Associated PAH
- CAD Testing, Treatment Changes After Malpractice Damage Caps
- Stroke Risk Highest in Paroxysmal Afib With Greater Burden of Afib
- New Hypertension Guideline Discussed for Older Adults
- Celecoxib Associated With Lower MACE Risk Than Naproxen and Ibuprofen
- Composite Echo Score Predicts PH in Interstitial Lung Disease
- Brain Natriuretic Peptide Shows Promise as Biomarker in Group 1 PAH
- NSAID Use Mediates CVD Risk in Osteoarthritis
- Perioperative Red Blood Cell Transfusions Linked to Postoperative VTE
- Good Sleep Tied to Better Cardiometabolic Health in Youths
- Walk Test Identifies Risk for Cognitive Dysfunction Post Cardiac Surgery
- Aldosterone Antagonists Improved Survival in STEMI Without Heart Failure